Tagraxofusp (Elzonris)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tagraxofusp (Elzonris), covering 2026-02-05 to 2026-02-05. Get the full timeline:
Most recent: Clinical Trial Update: A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax [Phase 1, Phase 2]